Schedule 13G ownership disclosure

SORRENTO THERAPEUTICS IN

Security class unavailable · CUSIP: 83587F202

Event date: 2020-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
460,588
Percent of class
0.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-020588
Form type
SC 13G/A
Filer
Ally Bridge Group Capital Partners II, L.P.
CIK
CIK 1609313
Filed
Feb 14, 2020
Reporting period
Feb 14, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub